Standout Papers

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-U... 2023 2026 202496
  1. Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up (2023)
    Thomas Powles, Se Hoon Park et al. Journal of Clinical Oncology

Immediate Impact

55 standout
Sub-graph 1 of 21

Citing Papers

Advances in diagnosis and treatment of bladder cancer
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
3 intermediate papers

Works of Claudia Caserta being referenced

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up
2023 Standout
Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data?
2022
and 3 more

Author Peers

Author Last Decade Papers Cites
Claudia Caserta 304 485 317 50 893
Renata Zaucha 228 445 286 51 1.0k
Charles K. Tashima 380 570 156 53 1.1k
Marlies Michl 373 683 219 46 1.1k
Catherine Shannon 280 681 184 48 1.1k
Priya Jayachandran 272 573 184 65 961
Cheng Fang 326 395 222 58 955
Alessandra Felici 351 475 163 49 1.1k
Keisuke Aiba 220 481 269 67 897
Yeu‐Tsu N. Lee 338 609 187 56 1.0k
Martine Patey 163 332 267 55 981

All Works

Loading papers...

Rankless by CCL
2026